Sunstone Biomedical Venture Annex I Overview
- Fund Type
-
Venture
- Fund Status
-
Fully Invested
- Fund Manager
- Sunstone Life Sc...
- Size
-
- Vintage
-
2004
- Dry Powder
-
Sunstone Biomedical Venture Annex I General Information
Description
Sunstone Biomedical Venture Annex I is a venture capital fund managed by Sunstone Life Science Ventures. The fund is located in Copenhagen, Denmark.
Contact Information
Fund Manager's Location
- Store Strandstræde 18
- 1255 Copenhagen
- Denmark
Sunstone Biomedical Venture Annex I Investments (4)
Sunstone Biomedical Venture Annex I has made a total of 4 investments. Its most recent deal was a with Zymenex. The deal was made on 01-May-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Zymenex | 01-May-2007 | Pharmaceuticals | Generating Revenue | |||
| Dentofit | 01-May-2007 | Other Devices and Supplies | Generating Revenue | |||
| Millimed | 01-May-2007 | Early Stage VC | Therapeutic Devices | Startup | ||
| Action Pharma | 27-Oct-2006 | Later Stage VC | Drug Discovery | Product Development |
Sunstone Biomedical Venture Annex I Investment Strategy
Investments by Industry
Investments by Deal Type
Sunstone Biomedical Venture Annex I Limited Partners (1)
ATP Private Equity Partners is the sole limited partner of Sunstone Biomedical Venture Annex I. Its latest Original was on 01-Dec-2004.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| ATP Private Equity Partners | Current | 01-Dec-2004 | Original |
Sunstone Biomedical Venture Annex I Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Sunstone Biomedical Venture Annex I Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Sunstone Biomedical Venture Annex I Benchmark (15)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Pantheon Venture Partners II | 30-Jun-2024 | ||||
| CS Venture I | |||||
| Viking Venture II | |||||
| Levensohn Venture Partners III | |||||
| EVP Early Stage Technology Fund | |||||
| Nauta Tech Invest I | |||||
| FCPI Poste Innovation 6 | |||||
| Innoven 2003 FCPI 7 | |||||
| Molins Capital Inversion | |||||
| NRW.BANK.Fonds Beteiligungs | 25-Sep-2019 |
Sunstone Biomedical Venture Annex I FAQs
-
What is Sunstone Biomedical Venture Annex I?
Sunstone Biomedical Venture Annex I is a venture capital fund managed by Sunstone Life Science Ventures.
-
Who manages Sunstone Biomedical Venture Annex I?
Sunstone Biomedical Venture Annex I is managed by Sunstone Life Science Ventures.
-
Where is Sunstone Biomedical Venture Annex I domiciled?
Sunstone Biomedical Venture Annex I is domiciled in Denmark.
-
What is Sunstone Biomedical Venture Annex I's size?
Sunstone Biomedical Venture Annex I has a size of .
-
What type of fund is Sunstone Biomedical Venture Annex I?
The fund type of Sunstone Biomedical Venture Annex I is Venture.
-
What is the status of Sunstone Biomedical Venture Annex I?
Sunstone Biomedical Venture Annex I is fully invested.
-
What has Sunstone Biomedical Venture Annex I invested in?
Sunstone Biomedical Venture Annex I has made numerous investments in companies like Zymenex, Dentofit, and Millimed within the Pharmaceuticals, Devices and Supplies, and Therapeutic Devices industries.
-
What has Sunstone Biomedical Venture Annex I invested in recently?
Sunstone Biomedical Venture Annex I's latest investment was on 01-May-2007 in Zymenex, a company within the Pharmaceuticals industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
